alexa Immunosupressive Properties of HLA-G Molecules Produced by Mesenchymal Stromal Cells | Open Access Journals
ISSN: 2161-0991
Journal of Transplantation Technologies & Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Immunosupressive Properties of HLA-G Molecules Produced by Mesenchymal Stromal Cells

Roberta Rizzo*

Department of Medical Sciences, Section of Microbiology and Medical Genetics, University of Ferrara, Ferrara, Italy

*Corresponding Author:
Roberta Rizzo
Department of Medical Sciences
Section of Microbiology and Medical Genetics
University of Ferrara, Via Luigi Borsari
46, I-44121 Ferrara, Italy
Tel: +390532455382
Fax: +390532974470
E-mail: [email protected]

Received Date: November 21, 2013; Accepted Date: November 21, 2013; Published Date: November 23, 2013

Citation: Rizzo R (2013) Immunosupressive Properties of HLA-G Molecules Produced by Mesenchymal Stromal Cells. J Transplant Technol Res 3: e127. doi: 10.4172/2161-0991.1000e127

Copyright: © 2013 Rizzo R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Transplantation Technologies & Research


Mesenchymal stromal cells; HLA-G; Immunosuppression

Human multipotent mesenchymal stromal cells (hMSCs), first described by Friedenstein in ’70 years [1] as non-hematopoietic cell precursors with osteogenic potential, represent stem cells for nonhematopoietic tissues [2]. The functional and immunophenotic characteristics of stromal cells have been recently reviewed and redefined by International Society for Cellular Therapy (ISCT) [3]: they must be defined as hMSCs, which are a plastic adherent cell population that retain in vitro clonogenic potential (defined by the presence of the fibroblast-colony forming unit, (CFU-F), capable of supporting hematopoiesis and having a differentiation capacity towards a number of different cell types (osteoblasts, chondrocytes, adipocytes, myocytes).

In the last years several studies have demonstrated the peculiar immunological characteristics of hMSCs, as low antigenicity and high immunomodulatory ability, suggesting their clinical use to counteract rejection in regenerative medicine and tissue transplantation. Cultured allogeneic hMSCs are widely used in clinical trials in hematopoietic stem cell infusion [4-6], in solid-organ transplantation [7] and for treating autoimmune diseases [8,9]. However, the in vivo data are still controversial and a specific marker for hMSCs selection is needed. The low antigenicity of hMSCs is mainly caused by the low expression of classical HLA (human leukocyte antigen) class I molecules and the complete absence of HLA class II antigens and co-stimulatory molecules as CD80 (B7-1), CD86 (B7-2) and CD40 [10]. The main interest in hMSCs is correlated with their ability to suppress the proliferation of T lymphocytes induced by mitogenic agents and alloantigens which regulate the transplantation rejection [11]. Moreover, hMSCs are resistant to the CD8+ T lymphocyte cytotoxicity, they are able to inhibit the differentiation of dendritic cells responsible for the antigen presentation, the proliferation and antibody production of B lymphocytes and they stimulate the formation of regulatory T cells. The mechanisms at the basis of hMSCs activity need cell-cell interaction and the production of molecules induced by the micro-environment. The inhibitory functions of hMSCs involve several molecules as hepatocyte growth factor, transforming growth factor-beta (TGFbeta), interleukin-10 and -2 (IL-10, IL-2), tumour necrosis factor-alpha (TNF-alpha), prostaglandin E2 (PGE2), indoleamine 2,3-dioxygenase (IDO) [12] and HLA-G antigens [13]. A large consesus has been obtained on the immuno-modulatory role of HLA-G molecules.

HLA-G antigen is a non-classical HLA class I molecule characterized by 7 mRNA splicing isoforms, 4 membrane-bound (HLA-G1, G2, G3, G4) and 3 soluble (HLA-G5, G6, G7). Both soluble and membranebound isoforms are able to inhibit several immune functions as lytic and cytotoxic activity of Natural Killer (NK) cells and T CD8+ lymphocytes, the maturation of dendritic cells, and the alloproliferation of CD4+ T lymphocytes and to induce the formation of regulatory T cells. HLA-G molecules differ from classical HLA antigens for their lower allelic polymorphism (50 alleles, and the limited tissue distribution. HLA-G expression is induced in pathological conditions, as tumours and viral infections [14]. Taking into consideration the tolerogenic functions of HLA-G molecules, they could be a good candidate as a factor for hMSCs immuno-modulatory activity. Götherström et al. [15] have demonstrated the presence of HLA-G mRNA in both fetal and adult hMSCs. The modulation of HLA-G has been documented on the surface of hMSCs [16] and in their culture supernatants [17]. Several studies have confirmed that the cell-cell contact between hMSCs and T lymphocyte induces the secretion of HLA-G molecules and IL-10, a cytokine that is able to upmodulate HLA-G production [17]. The use of neutralizing antibodies against HLA-G and IL-10 have demonstrated the importance of soluble HLA-G, induced by IL-10, for the suppressive effect of hMSCs towards cell proliferation [18,19], cytotoxic activity and IFN-γ secretion by NK cells, and the ability to induce regulatory T CD4+CD25high FoxP3+ cells formation [20]. These data suggest a fundamental role for HLA-G antigens in the tolerogenic function of hMSCs.

The selective use of HLA-G positive hMSCs could be a valuable tool in improving current protocols of hMSCs use as immunosuppressant cell biotherapy [21]. In fact, stable HLA-G expression by lentiviral system in hMSCs appeared to enhance the immunosuppressive effect of MSCs [22].

In conclusion, hMSCs are newly detected targets for immunomodulatory activity and HLA-G molecules could be an important factor of this mechanism.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11626
  • [From(publication date):
    December-2013 - Sep 21, 2017]
  • Breakdown by view type
  • HTML page views : 7847
  • PDF downloads :3779

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version